First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab. - Abstract - Europe PMC
Integrating anti-EGFR therapies in metastatic colorectal cancer - Haraldsdottir - Journal of Gastrointestinal Oncology
Cetuximab | Nature Reviews Drug Discovery
ERBITUX (cetuximab) for Head and Neck Cancer and Colorectal Cancer - Cancer Therapy Advisor
The road to resistance: EGFR mutation and cetuximab | Nature Medicine
Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
Targeted biotherapy in metastatic colorectal carcinoma: Current practice - ScienceDirect
Immune biomarkers of anti-EGFR monoclonal antibody therapy - Annals of Oncology
Anti-EGFR Mechanism of Action: Antitumor Effect and Underlying Cause of Adverse Events
Panitumumab - Dubois - 2009 - British Journal of Clinical Pharmacology - Wiley Online Library
Frontiers | The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells | Oncology
Predictive Biomarkers for Monoclonal Antibody Therapies Targeting EGFR ( Cetuximab, Panitumumab) in the Treatment of Metastatic Colorectal Cancer | IntechOpen
SMPDB
Clinical development of targeted and immune based anti-cancer therapies | Journal of Experimental & Clinical Cancer Research | Full Text
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines - Annals of Oncology
CETUXIMAB
The mechanism of cetuximab action. Notes: Schematic representation of... | Download Scientific Diagram
Gold nanoparticles conjugated to Cetuximab antibody against cancer - UABDivulga Barcelona Research & Innovation
Cetuximab - Classes of Monoclonal Antibodies: Endothelial Growth Factor Receptor (EGFR) Inhibitors
Mechanism of action of cetuximab, encorafenib and binimetinib. BRAF is... | Download Scientific Diagram
Frontiers | Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors | Oncology
Cetuximab - an overview | ScienceDirect Topics
Resistance to anti-epidermal growth factor receptor in metastatic colorectal cancer: What does still need to be addressed? - Cancer Treatment Reviews
Cetuximab Overview - Creative Biolabs
